The purpose of this Post Marketing Study is to study the safety and effectiveness of the ACRYSOF IQ PanOptix intraocular lens (IOL) in an Indian population.
The study population will consist of adult Indian males and females, at least 18 years of age or older at the time of screening, with no ocular pathology that could confound study outcomes, who are advised bilateral cataract extraction and who desire an IOL that provides the potential for correction of near, intermediate, and distance vision. Both eyes will be implanted. The second eye surgery will take place 15-30 days after the first eye surgery. Subjects will be followed for approximately 3 months after the second eye surgery. Total individual subject participation will be approximately 4 months. This study will be conducted in India.
Study Type
OBSERVATIONAL
Enrollment
80
Single-piece, ultraviolet and blue-light filtering, foldable, multifocal intraocular lens (IOL) inserted into the capsular bag during cataract surgery
Per investigator's standard of care
Alcon Investigative Site
Ahmedabad, Gujarat, India
Alcon Investigative Site
Chennai, Tamil Nadu, India
Alcon Investigative Site
Coimbatore, Tamil Nadu, India
Alcon Investigative Site
Bangalore, India
Best corrected binocular visual acuity at distance (4 m) at 3 months post bilateral implantation
Visual acuity will be assessed using Early Treatment Diabetic Retinopathy Study (ETDRS) charts and reported in logarithm minimum angle of resolution (logMAR).
Time frame: Month 3 (following second eye surgery)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Alcon Investigative Site
Hyderabad, India